Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
AssigneeSandoz Ltd.
InventorsBernt Pragl, Sabine Fuertinger
Life of this patent
Estimating the term…
Abstract
The present invention is related to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ≧0.7 and ≦5.
Claims17
A pharmaceutieally acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein, wherein the concentration ratio between the biopharmaceutical protein and the neutral salt is in the range of ≧0.7 and ≦5.
A method of increasing the stability of a pharmaceutically acceptable aqueous formulation comprising a biopharmaceutical protein, which method comprises providing the biopharmaceutical protein and the neutral salt in a final concentration ration in the range of ≧0.7 and ≦5.
Dependencies are inferred from the claim text.